Medical Isotopes / Petten Research Reactor In Netherlands Switches To 100% LEU Production

Move is part of an agreement reached with Barack Obama in 2014
Petten Research Reactor In Netherlands Switches To 100% LEU Production
The HFR research reactor at Petten in the Netherlands. Courtesy NRG.
The High Flux Reactor at Petten in the Netherlands will from now on only produce medical isotopes with low-enriched uranium (LEU), operator NRG announced on Thursday.

Until recently, production of medical isotopes for NRG’s Belgian partner the Institut National des Radioéléments (IRE) were still produced using high-enriched uranium (HEU) because IRE could not fully process low-enriched uranium.

IRE has now partially converted its chemical process to LEU, meaning NRG – the world’s largest producer of medical isotopes – can take the final step and stop production at the HFR using HEU.

As part of the Treaty on the Non-Proliferation of Nuclear Weapons (NPT), which has been signed by 191 states, a consensus was reached on phasing out the use of HEU, which can be used to produce nuclear weapons.

Want to keep reading?

Register free and get full access to NucNet for 14 days. No card required.

Republish or license this article

MORE THAN 30 YEARS OF NUCLEAR INDUSTRY REPORTING.

Subscribe for full access to every article, the archive and the SMR and AMR database.

Join NucNet